OncoGenex Pharmaceuticals Inc is a biopharmaceutical company committed to the development and commercialization of new cancer therapies that address treatment resistance in cancer patients.


Updates from The Motley Fool

Latest updates on OncoGenex Pharmaceuticals from Fool.com.


Stock Performance

OGXI vs. S&P 500 | 2 Year Performance
View Interactive OGXI Charts
Sponsored by

Key Data Points

Primary metrics and data points about OncoGenex Pharmaceuticals.
Current Price: $0.55
Prev Close: $0.55
Open: $0.55
Bid: $0.55
Ask: $0.56
Day's Range: $0.54 - $0.56
52wk Range: $0.46 - $3.38
Volume: 18,371
Avg Vol 335,551
Market Cap: $16.45M
P/E (ttm): -1.04
EPS (ttm): -$0.53
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about OncoGenex Pharmaceuticals.
CAPS Rating 2 out of 5
 
100 Outperform
38 Underperform
CAPS All Stars
 
18 Outperform
13 Underperform

How do you think OncoGenex Pharmaceuticals will perform against the market?



You pick for OncoGenex Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for OncoGenex Pharmaceuticals.

OncoGenex Pharmaceuticals Inc is a biopharmaceutical company committed to the development and commercialization of new cancer therapies that address treatment resistance in cancer patients.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers